ideal-candidate-stem-cell-therapy-canditato-ideal-tratamiento-celulas-madre
FAQ's
Answer : According to Precedence Research, the global next-generation sequencing market size was reached at USD 5.5 billion in 2020 and is predicted to be worth around USD 24.48 billion by 2030.
Answer : The global next-generation sequencing market is expected to grow at a CAGR of 16.1% from 2021 to 2030.
Answer : The major players operating in the next-generation sequencing market are BGI Group, F. Hoffmann-La Roche AG, Pacific Biosciences of California Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Precigen Inc., Illumina Inc., Qiagen N.V., PerkinElmer Inc., PierianDx Inc..
Answer : The use of next-generation sequencing in the development of customized therapeutics at the generic level is expected to increase demand for next-generation sequencing in the future years. The increased applications of next-generation sequencing (NSG) in chronic diseases and oncology are projected to drive the next-generation sequencing market.
Answer : North America region will lead the global next-generation sequencing market.
Get a Sample of this Report
ideal-candidate-stem-cell-therapy-canditato-ideal-tratamiento-celulas-madre
